3X Genetics
Targeted Long-Read Genetic Testing for Repeat Expansion Disorders
Worcester, United States · Founded 2021 · $3.2M raised
- Headquarters
- Worcester, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- 3xgenetics.com
- Total Funding
- $3.2M
- Last Round
- $3.2M SeedMar 2026
- Rounds
- 1
About
3X Genetics is a diagnostics company based in Worcester, MA with a CLIA-certified lab in Manchester, NH. Founded in 2021, it develops precision tests for repeat expansion disorders and other genetic diseases using AI-driven assay design with targeted long-read sequencing, partnering with biopharma and research institutions.
Summary
3X Genetics is a Biotech company based in Worcester, United States, founded in 2021. It has raised $3.2M in total across 1 round, most recently a $3.2M Seed round in Mar 2026. Investors include Alumni Ventures and Morningside Group.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...